These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27832204)

  • 1. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
    Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
    PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.
    Zhou C; Huang C; Wang J; Huang H; Li J; Xie Q; Liu Y; Zhu J; Li Y; Zhang D; Zhu Q; Huang C
    Oncogene; 2017 Jul; 36(27):3878-3889. PubMed ID: 28263966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA MEG3 plays a promoting role in the proliferation, invasion, and angiogenesis of lung adenocarcinoma cells through the AKT pathway.
    Li H; Wang J; Lv S; Zhang Y; Zhang C; Lige B; Dan S; Sun Y
    J Cell Biochem; 2019 Sep; 120(9):16143-16152. PubMed ID: 31211438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property.
    Lin HP; Rea M; Wang Z; Yang C
    Toxicol Appl Pharmacol; 2021 Nov; 430():115724. PubMed ID: 34520792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.
    Pan T; Ding H; Jin L; Zhang S; Wu D; Pan W; Dong M; Ma X; Chen Z
    Cell Cycle; 2022 Nov; 21(21):2323-2337. PubMed ID: 35822955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNMT1 protein promotes retinoblastoma proliferation by silencing MEG3 gene].
    Gao Y; Luo X; Meng T; Zhu M; Tian M; Lu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1239-1245. PubMed ID: 32990237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
    Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
    Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
    Modali SD; Parekh VI; Kebebew E; Agarwal SK
    Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p.
    Wu JL; Meng FM; Li HJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5938-5945. PubMed ID: 30280775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
    Su L; Han D; Wu J; Huo X
    Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aberrant Expression of Rb and pRb-780, pRb-795 in Lung Adenocarcinoma Patients with EGFR Mutations and Their Clinical Significance].
    Dong Y; Liu M; Li Y; Li Y; Zhao C; Yuan Y; Du H; Zhang Z; Zhang H; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):312-317. PubMed ID: 28532538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
    Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.
    Zhuo H; Tang J; Lin Z; Jiang R; Zhang X; Ji J; Wang P; Sun B
    Mol Carcinog; 2016 Feb; 55(2):209-19. PubMed ID: 25641194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
    Terashima M; Tange S; Ishimura A; Suzuki T
    J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.
    Dong X; Wang J; Li T; Xu YP; Li SY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8265-8272. PubMed ID: 30556866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.